Rebecca D Jackson, MD
College of Medicine
>Hip Fractures ● Breast Cancer ● Colorectal Cancer ● Cancer ● Coronary Disease ● Body Mass Index ● Osteoporosis ● stroke ● Osteoarthritis ● Brain Injuries
Rebecca Jackson, MD, is a member of the Cancer Control Program at the OSUCCC – James, where she is involved in collaborative multidisciplinary team science. Her work focuses on the epidemiology of chronic disease in women, including cancer, osteoporosis, cardiovascular disease and osteoarthritis.Recently, she was one of the researchers in a genome-wide association study of marginal zone lymphoma (MZL), which revealed the first evidence that genetic variation in the major histocompatibility complex influences MZL susceptibility. Throughout her multi-decade career, Dr. Jackson, who also directs the Center for Clinical and Translational Science (CCTS) at Ohio State, has co-authored hundreds of articles that have appeared in such well-respected publications as American Journal of Preventive Medicine, Arthritis & Rheumatology, Nature and Nature Communications.